Tao Xin

852 total citations
40 papers, 622 citations indexed

About

Tao Xin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tao Xin has authored 40 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Tao Xin's work include Lung Cancer Treatments and Mutations (12 papers), Polysaccharides and Plant Cell Walls (7 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Tao Xin is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Polysaccharides and Plant Cell Walls (7 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Tao Xin collaborates with scholars based in China, United States and Japan. Tao Xin's co-authors include Qiuying Jiang, Weixi Shen, Dayong Huang, Fubin Zhang, Yinghua Jin, Chunhong Chen, Sui Li-hua, Ying‐Hua Jin, Xiaowei Song and Guangjie Sui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Tao Xin

36 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tao Xin China 16 277 162 150 138 91 40 622
Weixi Shen China 14 181 0.7× 155 1.0× 138 0.9× 115 0.8× 89 1.0× 28 580
Qiuying Jiang China 12 166 0.6× 95 0.6× 95 0.6× 141 1.0× 45 0.5× 23 462
Qunguang Jiang China 14 186 0.7× 152 0.9× 148 1.0× 63 0.5× 91 1.0× 31 555
Wensheng Zhang China 18 507 1.8× 105 0.6× 115 0.8× 151 1.1× 152 1.7× 55 870
Yan‐Jiun Huang Taiwan 17 354 1.3× 226 1.4× 89 0.6× 187 1.4× 135 1.5× 48 901
Hua-Tao Wu China 15 476 1.7× 221 1.4× 147 1.0× 72 0.5× 242 2.7× 38 846
Yi-Li Feng China 14 378 1.4× 143 0.9× 46 0.3× 112 0.8× 114 1.3× 24 673
Lei Gong China 15 378 1.4× 158 1.0× 76 0.5× 50 0.4× 129 1.4× 45 700
Rusong Zhang China 19 536 1.9× 153 0.9× 282 1.9× 155 1.1× 136 1.5× 77 947
Yougen Wu China 12 302 1.1× 120 0.7× 54 0.4× 62 0.4× 133 1.5× 24 573

Countries citing papers authored by Tao Xin

Since Specialization
Citations

This map shows the geographic impact of Tao Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Xin more than expected).

Fields of papers citing papers by Tao Xin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Xin. The network helps show where Tao Xin may publish in the future.

Co-authorship network of co-authors of Tao Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Xin. A scholar is included among the top collaborators of Tao Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Xin. Tao Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Hai‐Ning, Tao Xin, Jinbo Liu, et al.. (2025). Inflammatory responsive hydrogels incorporated with bevacizumab-loaded infinite coordination nanopolymers for accelerating cartilage repair. Journal of Colloid and Interface Science. 700(Pt 3). 138484–138484.
2.
Lin, Gen, Yongsheng Wang, Tao Xin, et al.. (2025). Chinese Expert Consensus on Leptomeningeal Metastases of Lung Cancer. Thoracic Cancer. 16(11). e70088–e70088.
3.
Xin, Tao, Xianxiang Chen, Ruihong Dong, et al.. (2024). Characterization and antioxidant properties of three exopolysaccharides produced by the Cyclocarya paliurus endophytic fungus. International Journal of Biological Macromolecules. 271(Pt 1). 132110–132110. 10 indexed citations
4.
Fan, Chengjuan, Che‐Ming Teng, Xiaowei Song, et al.. (2024). Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial. ESMO Open. 9(4). 102384–102384. 16 indexed citations
5.
6.
Chen, Daiwen, Liuming Xie, Pingwei Wen, et al.. (2024). Alkali-extracted polysaccharides from mung bean skin possess protective effect on H 2O 2-induced IEC-6 cells: the role of NF-κB and MAPK signaling pathways. Food Science and Human Wellness. 14(1). 9250006–9250006.
7.
8.
Zhao, Zitong, et al.. (2020). [Acquired Drug Resistance Mechanism of Osimertinib in the Targeted Therapy of Non-small Cell Lung Cancer].. SHILAP Revista de lepidopterología. 23(4). 274–281. 1 indexed citations
9.
Xing, Puyuan, Shouzheng Wang, Di Ma, et al.. (2019). Efficacy of Crizotinib for Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Patients with Brain Metastasis: A Multicenter, Retrospective Study in China. Targeted Oncology. 14(3). 325–333. 8 indexed citations
10.
Ma, Di, Yan Zhang, Puyuan Xing, et al.. (2019). Clinical features and outcomes ofALKrearranged non‐small cell lung cancer with primary resistance to crizotinib. Thoracic Cancer. 10(5). 1213–1219. 5 indexed citations
11.
Xing, Puyuan, Di Ma, Xuezhi Hao, et al.. (2019). Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study. Chinese Journal of Cancer Research. 31(3). 481–488. 6 indexed citations
12.
Xin, Tao, Xiaoxia Yang, Liang Yang, et al.. (2019). miR-629–5p promotes growth and metastasis of hepatocellular carcinoma by activating β-catenin. Experimental Cell Research. 380(2). 124–130. 18 indexed citations
13.
Xu, Yan, Li Zhang, Jian Fang, et al.. (2018). Establishment of a prospective multicenter cohort for advanced non‐small cell lung cancer in China (CAPTRA‐Lung study). Thoracic Cancer. 9(12). 1795–1800. 4 indexed citations
14.
Liu, Ying, Tao Xin, Dayong Huang, et al.. (2014). Prognosis in very young women with triple-negative breast cancer: retrospective study of 216 cases. Medical Oncology. 31(12). 222–222. 14 indexed citations
15.
Zhang, Fubin, Xiaowei Song, Li Li, et al.. (2014). Polygala tenuifolia polysaccharide PTP induced apoptosis in ovarian cancer cells via a mitochondrial pathway. Tumor Biology. 36(4). 2913–2919. 25 indexed citations
16.
Liu, Ying, Tao Xin, Qi Jiang, et al.. (2013). CD147, MMP9 expression and clinical significance of basal-like breast cancer. Medical Oncology. 30(1). 366–366. 28 indexed citations
17.
Jiang, Qiuying, et al.. (2012). Clinical Significance of Basal-like Breast Cancer in Chinese Women in Heilongjiang Province. Asian Pacific Journal of Cancer Prevention. 13(6). 2735–2738. 4 indexed citations
18.
Xin, Tao, et al.. (2012). Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity. British Journal of Biomedical Science. 69(2). 62–66. 14 indexed citations
19.
Xin, Tao, Fubin Zhang, Qiuying Jiang, et al.. (2012). Extraction, purification and antitumor activity of a water-soluble polysaccharide from the roots of Polygala tenuifolia. Carbohydrate Polymers. 90(2). 1127–1131. 49 indexed citations
20.
Li-hua, Sui, et al.. (2008). Correlations of BMI-1 expression and telomerase activity in ovarian cancer tissues.. PubMed. 30(1). 70–4. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weixi Shen Breakdown of academic impact, for papers by Qiuying Jiang Breakdown of academic impact, for papers by Qunguang Jiang Breakdown of academic impact, for papers by Wensheng Zhang Breakdown of academic impact, for papers by Yan‐Jiun Huang Breakdown of academic impact, for papers by Hua-Tao Wu Breakdown of academic impact, for papers by Yi-Li Feng Breakdown of academic impact, for papers by Lei Gong Breakdown of academic impact, for papers by Rusong Zhang Breakdown of academic impact, for papers by Yougen Wu
Rankless by CCL
2026